申请人:DESTINY PHARMA LTD
公开号:WO2006000765A1
公开(公告)日:2006-01-05
The invention provides the use of a compound of Formula (I), or metallated derivative thereof, in the preparation of a medicament for killing or attenuating the growth of microorganisms by a method which does not comprise exposing the compound to a photodynamic therapy light source or a sonodynamic therapy ultrasound source Formula (I) wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 and Z have meanings given in the description. Preferably, the microorganisms are selected from the group consisting off bacteria, mycoplasmas, yeasts, fungi and viruses.
该发明提供了使用化合物Formula(I)或其金属化衍生物在制备药物时用于杀灭或减轻微生物生长的方法,该方法不包括将该化合物暴露于光动力疗法光源或声动力疗法超声源中。Formula(I)中X1、X2、X3、X4、Y1、Y2、Y3、Y4和Z的含义如描述中所给。优选微生物选自细菌、支原体、酵母菌、真菌和病毒。